Roger Sawhney
CIK 1858748 · Chief Financial Officer · last filed 2026-06-10
Roger Sawhney is a Chief Financial Officer who has filed 8 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for ABUS, was dated Jun 10, 2026. Across all open-market trades the lifetime net is +$50.0K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
8
$50.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABUS | Director | — | $4.26 | — | $0 | 2 | 2026-06-10 |
| ACTU | Director | — | $2.02 | — | $0 | 3 | 2026-05-22 |
| ALIMERA SCIENCES INC (ALIM) Delisted | Director | — | $5.54 | — | $0 | 1 | 2023-03-01 |
| Omega Therapeutics, Inc. (OMGA) Delisted | Chief Financial Officer | 2,941 | $0.14 | $419 | $50.0K | 2 | 2022-03-11 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | ABUS | Grant (A) | — | $0 | EDGAR |
| 2026-05-22 | ACTU | Grant (A) | — | $0 | EDGAR |
| 2025-08-06 | ABUS | Grant (A) | — | $0 | EDGAR |
| 2025-05-23 | ACTU | Grant (A) | — | $0 | EDGAR |
| 2024-08-14 | ACTU | Grant (A) | — | $0 | EDGAR |
| 2023-03-01 | ALIMERA SCIENCES INC (ALIM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-11 | Omega Therapeutics, Inc. (OMGA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-03 | Omega Therapeutics, Inc. (OMGA) Delisted | Buy (P) | +2,941 | $50.0K | EDGAR |